Mark R. Conaway, Ph.D.

Public Health Sciences
 

Mark R. Conaway, Ph.D.

Professor
Director of Translational Research
Office of the Chair
Ph.D., Statistics, University of Minnesota, 1985

P.O. Box 800717
Tel: 1-434-924-8510
Fax: 1-434-924-8437
Email: mconaway@virginia.edu
OMS Room 3877

Expertise:

Design and analysis for clinical trials; Statistical methods for animal models; Longitudinal data.

Research Interests:

Dr. Conaway's areas of research interest include: missing data, design of phase I and phase II clinical trials, and developing reference norms.

Teaching Responsibilities:

STAT5310 Statistical Methods for Clinical Trials
Micr8380 Practical Biostatistics

Recent Publications

Wages, N. , Conaway, M. and O’Quigley, J. (2011) Continual reassessment method for partial ordering, Biometrics. Feb 24 [epub ahead of print]

O’Quigley, J. and Conaway, M. Extended model based designs for more complex dose finding studies (2011) Statistics in Medicine. Feb 24. [epub ahead of print] PMID: 21351287

Petroni, G. and Conaway, M. (in press, 2011) "Phase II trials with combined response and toxicity endpoints", in Handbook of Statistics in Clinical Oncology, 3nd edition, ed. Crowley, J. Marcel Dekker.

Wages, N. , Conaway, M. and O’Quigley, J. (in press, 2011), “Dose-finding Design for Multi-drug Combinations", Clinical Trials: Journal of the Society for Clinical Trials

O’Quigley, J. and Conaway, M. (2010) Continual Reassessment and Related Dose-Finding Designs. Statistical Science, Vol. 25, No. 2, 202–216.

Johnston, K., Hall,C., Kissela, B., Bleck, T. and Conaway, M. for the GRASP Investigators (2009) Glucose Regulation in Acute Stroke Patients (GRASP) Trial. A Randomized Pilot Trial. Stroke 40: 12, 3804-3809. PMID: 19834016. PMC2790382

Burns, T., Conaway, M., Cutter, G., Sanders, D. and the Muscle Study Group. (2008) Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite. Muscle and Nerve 38: 1153-1562. PMID: 19016543

Gordon, V., Bhadel, S. , Wunderlich, W., Zhang, J., Ficarro, S., Mollah, S., Shabanowitz, J., Hunt, D., Xenarios, I., Hahn, W., Conaway, M. Carey, M and Gioeli, D. CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation (2010), Molecular Endocrinology, 24(12):2267-80. PMID: 20980437

Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, Jacobs BR, Jefferson LS, Conaway MR, Egan EA, and members of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) (2005) “Effect of Exogenous Surfactant (Calfactant) in Pediatric Acute Lung Injury, Journal of the American Medical Association 293 (4): 470-476

Conaway,M , Dunbar, S., and Peddada, S. (2004) “Designs for single or multiple agent phase I trials”, Biometrics, 60, 661-669.